AIM
VIVS

Acrospire Investment Management’s VivoSim Labs VIVS Stock Holding History

Acrospire Investment Management’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-73
Closed -$60K – 2548
2016
Q4 		$60K Buy
73
+69
+1,725% +$54.8K 0.02% 1283
2016
Q3 		$4K Buy
+4
New +$3.92K ﹤0.01% 1862

Other funds holding VIVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Acrospire Investment Management's VIVS Position: Q1 2017 in Review

Acrospire Investment Management sold out of VivoSim Labs (VIVS) in Q1 2017, closing a stake of 73 shares — an estimated $60K sold.

Acrospire Investment Management first reported a position in VIVS in Q3 2016 and held it in 2 quarters. The position peaked at $60K in Q4 2016. 115 funds tracked by Wall St. Rank hold VIVS as of Q1 2017.

  • Acrospire Investment Management reported no remaining VivoSim Labs position as of Q1 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 73 VivoSim Labs shares in Q1 2017, an estimated $60K.
  • Acrospire Investment Management first reported a position in VivoSim Labs in Q3 2016 and held it in 2 quarters.
  • Acrospire Investment Management's VivoSim Labs position peaked at $60K in Q4 2016.
  • 115 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2017.

Based on Acrospire Investment Management's 13F filing for Q1 2017, filed 4 May 2017.